disulfiram and folic acid

disulfiram has been researched along with folic acid in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19902 (22.22)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (66.67)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Ekins, S; Williams, AJ; Xu, JJ1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Casagrande, G; Michot, F1
Gibbs, DA; Watts, RW1
Dinarvand, R; Esfandyari-Manesh, M; Faghihi, S; Fasehee, H; Ghaffari, SH; Ghavamzadeh, A; Moradian, H1
Bu, W; Chen, M; Chen, X; Cui, J; Li, W; Li, X; Liu, C; Liu, J; Meng, L; Sun, H; Wang, J1

Reviews

1 review(s) available for disulfiram and folic acid

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

1 trial(s) available for disulfiram and folic acid

ArticleYear
Alcohol-induced bone marrow damage: status before and after a 4-week period of abstinence from alcohol with or without disulfiram. A randomized bone marrow study in alcohol-dependent individuals.
    Blut, 1989, Volume: 59, Issue:3

    Topics: Alcoholism; Bone Marrow; Disulfiram; Erythroblasts; Erythrocytes, Abnormal; Ethanol; Ferritins; Folic Acid; Hematocrit; Hematopoiesis; Humans; Leukocyte Count; Liver; Platelet Count; Vitamin B 12

1989

Other Studies

7 other study(ies) available for disulfiram and folic acid

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
Biochemical studies on the treatment of primary hyperoxaluria.
    Archives of disease in childhood, 1967, Volume: 42, Issue:225

    Topics: Adolescent; Allopurinol; Child; Dietary Proteins; Disulfiram; Enzyme Inhibitors; Female; Folic Acid; Humans; Male; Metabolic Diseases; Oxalates; Pyridoxine; Vitamin K

1967
Delivery of disulfiram into breast cancer cells using folate-receptor-targeted PLGA-PEG nanoparticles: in vitro and in vivo investigations.
    Journal of nanobiotechnology, 2016, Apr-21, Volume: 14

    Topics: Breast Neoplasms; Cell Line, Tumor; Cell Survival; Disulfiram; Drug Carriers; Female; Folate Receptors, GPI-Anchored; Folic Acid; Humans; Lactic Acid; MCF-7 Cells; Nanoparticles; Particle Size; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer

2016
Folic acid-modified disulfiram/Zn-IRMOF3 nanoparticles for oral cancer therapy by inhibiting ALDH1A1+ cancer stem cells.
    Biomaterials advances, 2022, Volume: 139

    Topics: Aldehyde Dehydrogenase 1 Family; Antineoplastic Agents; Disulfiram; Folic Acid; Humans; Mouth Neoplasms; Nanoparticles; Neoplastic Stem Cells; Organometallic Compounds; Retinal Dehydrogenase; Zinc

2022